© 2020 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2020 MJH Life Sciences™ and Formulary Watch. All rights reserved.
Recent FDA action (through May 2011) related to Augment Bone Graft, crizotinib, DP-b99 development program, regorafenib, MCD-386CR, liver cell infusion of donated human liver cells
Recommended for approval